Suppr超能文献

人血和血管细胞中的前列腺素 E2 受体亚型。

Prostaglandin E2 receptor subtypes in human blood and vascular cells.

机构信息

Department of Pharmacy, Faculty of Medicine, Ferhat Abbas University, Setif, Algeria.

出版信息

Eur J Pharmacol. 2012 Nov 15;695(1-3):1-6. doi: 10.1016/j.ejphar.2012.08.009. Epub 2012 Sep 3.

Abstract

Prostaglandin E(2) is produced in inflammatory responses via the cyclooxygenase pathway and regulates a variety of physiological and pathological reactions through four different receptor subtypes; EP(1), EP(2), EP(3) and EP(4). The role of the classical prostanoid receptors stimulated by prostaglandin I(2) and thromboxane A(2) in the blood circulation has been largely studied, whereas the other receptors such as EP activated by prostaglandin E(2), have been recently shown to be also implicated. There is now increasing evidence suggesting an important role of EP(3) and EP(4) receptor subtypes in the control of the human vascular tone and remodeling of the vascular wall as well in platelet aggregation and thrombosis. These receptors are implicated in vascular homeostasis and in the development of some pathological situations, such as atherosclerosis, aneurysms and hypertension. The use of specific EP agonists/antagonists would provide a novel cardiovascular therapeutic approach. In this review, we discuss the role of prostaglandin E(2) receptors in the control of human blood and vascular cells.

摘要

前列腺素 E(2) 通过环氧化酶途径在炎症反应中产生,并通过四种不同的受体亚型 EP(1)、EP(2)、EP(3) 和 EP(4) 调节各种生理和病理反应。已经对前列腺素 I(2) 和血栓素 A(2) 刺激的经典前列腺素受体在血液循环中的作用进行了大量研究,而其他受体,如前列腺素 E(2) 激活的 EP 受体,最近也被证明与之相关。越来越多的证据表明,EP(3) 和 EP(4) 受体亚型在控制人类血管张力和血管壁重塑以及血小板聚集和血栓形成方面起着重要作用。这些受体参与血管内稳态和一些病理情况的发展,如动脉粥样硬化、动脉瘤和高血压。特异性 EP 激动剂/拮抗剂的使用将提供一种新的心血管治疗方法。在这篇综述中,我们讨论了前列腺素 E(2) 受体在控制人类血液和血管细胞中的作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验